Assessing The Evidence For Value-Based Insurance Design

被引:71
作者
Choudhry, Niteesh K. [1 ,2 ]
Rosenthal, Meredith B. [3 ]
Milstein, Arnold [4 ,5 ,6 ]
机构
[1] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
[2] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA
[4] Stanford Univ, Stanford, CA 94305 USA
[5] Stanford Clin Excellence Res Ctr, Stanford, CA USA
[6] Mercer Hlth & Benefits, San Francisco, CA USA
关键词
MEDICATION ADHERENCE; PRESCRIPTION DRUGS; COST-EFFECTIVENESS; COVERAGE; INFARCTION; IMPACT; HOSPITALS; BENEFITS; TRIAL; CARE;
D O I
10.1377/hlthaff.2009.0324
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
High copayments for medical services can cause patients to underuse essential therapies. Value-based health insurance design attempts to address this problem by explicitly linking cost sharing and value. Copayments are set at low levels for high-value services. The Mercer National Survey of Employer-Sponsored Health Plans demonstrates that value-based insurance design use is increasing and that 81 percent of large employers plan to offer it in the near future. Despite this increase, few studies have adequately evaluated its ability to improve quality and reduce health spending. Maximizing the benefits of value-based insurance design will require mechanisms to target appropriate copayment reductions, offset short-run cost outlays, and expand its use to other health services.
引用
收藏
页码:1988 / 1994
页数:7
相关论文
共 26 条
[1]
Impact of decreasing copayments on medication adherence within a disease management environment [J].
Chernew, Michael E. ;
Shah, Mayur R. ;
Wegh, Arnold ;
Rosenberg, Stephen N. ;
Juster, Iver A. ;
Rosen, Allison B. ;
Sokol, Michael C. ;
Yu-Isenberg, Kristina ;
Fendrick, A. Mark .
HEALTH AFFAIRS, 2008, 27 (01) :103-112
[2]
Value-based insurance design [J].
Chernew, Michael E. ;
Rosen, Allison B. ;
Fendrick, A. Mark .
HEALTH AFFAIRS, 2007, 26 (02) :W195-W203
[3]
Evidence That Value-Based Insurance Can Be Effective [J].
Chernew, Michael E. ;
Juster, Iver A. ;
Shah, Mayur ;
Wegh, Arnold ;
Rosenberg, Stephen ;
Rosen, Allison B. ;
Sokol, Michael C. ;
Yu-Isenberg, Kristina ;
Fendrick, A. Mark .
HEALTH AFFAIRS, 2010, 29 (03) :530-536
[4]
Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies [J].
Choudhry, Niteesh K. ;
Brennan, Troyen ;
Toscano, Michele ;
Spettell, Claire ;
Glynn, Robert J. ;
Rubino, Mark ;
Schneeweiss, Sebastian ;
Brookhart, Alan M. ;
Fernandes, Joaquim ;
Mathew, Susan ;
Christiansen, Blake ;
Antman, Elliott M. ;
Avorn, Jerry ;
Shrank, William H. .
AMERICAN HEART JOURNAL, 2008, 156 (01) :31-36
[5]
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction medicare beneficiaries [J].
Choudhry, Niteesh K. ;
Patrick, Amanda R. ;
Antman, Elliott M. ;
Avorn, Jerry ;
Shrank, William H. .
CIRCULATION, 2008, 117 (10) :1261-1268
[6]
Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis [J].
Choudhry, Niteesh K. ;
Avorn, Jerry ;
Antman, Elliott M. ;
Schneeweiss, Sebastian ;
Shrank, William H. .
HEALTH AFFAIRS, 2007, 26 (01) :186-194
[7]
Cranor Carole W, 2003, J Am Pharm Assoc (Wash), V43, P173, DOI 10.1331/108658003321480713
[8]
Fendrick AM, 2006, AM J MANAG CARE, V12, pSP5
[9]
Fendrick AM, 2001, AM J MANAG CARE, V7, P861
[10]
Prescription drug cost sharing associations with medication and medical utilization and spending and health [J].
Goldman, Dana P. ;
Joyce, Geoffrey F. ;
Zheng, Yuhui .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (01) :61-69